SYNTEC OPTICS HOLDINGS, INC.

Syntec Optics Holdings, Inc. announced receipt of new orders for two additional ballistic-grade display windows, significantly expanding its product portfolio for soldier Augmented Reality (AR) systems. This development marks a substantial expansion of the company's role in U.S. military AR modernization. The new awards, which include windows for advanced eye-tracking and specialized illumination, are seen by the CFO as the start of a decade-long supply program for next-generation, domestically sourced defense architecture, crucial for AI-powered battlefield navigation.

Syntec Optics Holdings, Inc. announced a 40% increase in orders for optical sub-systems used in advanced laser-guides for missiles, bringing the total order value to over $1.2 million. This significant growth reflects an urgent need to replenish U.S. and allied military inventories with combat-proven technology. The company has already fulfilled about 23% of these orders and anticipates continued expansion in the defense sector.

Syntec Optics Holdings, Inc. announced a new order to expand and modularize its ballistic optics product line for advanced AR/VR glasses. This initiative is designed to support U.S. warfighters with AI-enhanced perception and decision-making capabilities, providing critical tactical advantages. The company highlights its role in a significant, multi-year defense initiative, positioning itself to support a broader family of AR glasses. The defense AR/VR market is projected to grow from $1.68 billion in 2025 to $4.34 billion in 2030.

Syntec Optics announced it secured nearly $4 million in new U.S. life sciences purchase orders, adding to previously announced $4.6 million in orders for laser blood analysis optics. These new contracts cover a diverse range of products for applications such as surgical robotics, DNA sequencing, and biomedical visualization. The company emphasizes its role in providing critical optical solutions for advancing healthcare technologies and patient care.

Syntec Optics Holdings, Inc. announced new purchase orders totaling nearly $2.4 million for its Low Earth Orbit (LEO) satellite optics product line. This expands a previously announced nearly $1.9 million order, bringing the total recent awards for this product line to nearly $4.3 million, with full delivery expected before the middle of next quarter. The company highlights its critical contribution to the expanding space economy, with tens of thousands of its optics already operational in LEO, enabling high-speed data transfers and global connectivity.

Syntec Optics announced a new $4.6 million purchase order for the continued manufacturing of advanced laser blood-test cartridges and optical reader subsystems. These products are crucial for benchmark instrumentation used in clinics and hospitals worldwide, providing consumable diagnostics for hemoglobin, electrolytes, and metabolites. The company expects to complete full delivery by Q3, reinforcing its established mission-critical BioMed product lines as a stable and diversified revenue source.

Syntec Optics announced its selection for inclusion in the Russell 3000® Index, effective after the U.S. market closes on June 26, 2026. This milestone reflects the company's operational and financial efforts, signaling its ability to meet minimum price, volume, and market-cap thresholds. The inclusion is expected to enhance institutional visibility and broaden exposure to the investment community, as approximately $10.6 trillion in investment assets are benchmarked against Russell U.S. indexes.

Syntec Optics Holdings, Inc. announced the successful delivery of pioneering next-generation products for defense tech, space tech, and Artificial Intelligence platforms, achieving high accuracy in nanoscale irregularity. These milestones, achieved over 12 months, include ultra-precision mirrors for multi-spectral defense, advanced satellite optics for consumer and space-based tracking, and nano-surfaced gates for the Artemis rocket launcher. The company highlighted its disciplined innovation strategy, transitioning advanced military space technology to commercial markets and supplying critical optics for space-solar and fusion energy to power hyperscale AI data centers.

Syntec Optics reported a Q1 2026 net loss of approximately $(0.9) million, or $(0.02) per diluted share, on revenue of $6.5 million, down from $7.1 million in Q1 2025. The decline was attributed to temporary shipment timing delays in biomedical markets and a $1 million reduction in production volume in January. Subsequent to quarter-end, the company successfully completed a public offering, raising approximately $21.5 million in net proceeds, significantly strengthening its balance sheet and liquidity. Syntec Optics anticipates improved operating momentum and net sales higher than $7.5 million in Q2 2026.

SYNTEC OPTICS HOLDINGS, INC. reported a net loss of $(0.02) per share for the first quarter of 2026, a decline from net income of $0.01 per share in the prior year, with net sales decreasing to $6.51 million. However, the company significantly strengthened its financial position through subsequent events, raising approximately $21.4 million in net proceeds from a public equity offering. This capital was used to fully repay its $6.8 million line of credit, resolving prior non-compliance with financial covenants and extending its revolving credit facility.